Difficulty: Medium
Average Score: 76%
Practice
Currently used oral hypoglycemic biguanides include the following, EXCEPT:
Correct answer
A
Rationale
In this question, the correct answer is A) Repaglinide (Prandin) because it is not a biguanide, but rather a meglitinide oral hypoglycemic agent. Metformin and Phenformin are both biguanides commonly used to treat type 2 diabetes by decreasing glucose production in the liver and improving insulin sensitivity. Glipizide, on the other hand, belongs to the sulfonylurea class of medications that stimulate the pancreas to release more insulin.
Understanding the differences between these medications is crucial for healthcare providers, especially those involved in managing diabetes treatment. Metformin is a first-line therapy for type 2 diabetes due to its safety profile and beneficial effects on weight and cardiovascular risk factors. Phenformin, although effective, is associated with a higher risk of lactic acidosis and has been largely replaced by safer alternatives like metformin. Glipizide is another common oral antidiabetic drug but belongs to a different class with different mechanisms of action and side effect profiles.
Educationally, this question helps reinforce the importance of drug classification and understanding the mechanisms of action of commonly prescribed medications for diabetes management. It highlights the need for healthcare providers to be familiar with the different classes of oral hypoglycemic agents to make appropriate treatment choices based on individual patient needs and characteristics. This knowledge is essential for optimizing patient outcomes and minimizing medication-related risks in clinical practice.
Understanding the differences between these medications is crucial for healthcare providers, especially those involved in managing diabetes treatment. Metformin is a first-line therapy for type 2 diabetes due to its safety profile and beneficial effects on weight and cardiovascular risk factors. Phenformin, although effective, is associated with a higher risk of lactic acidosis and has been largely replaced by safer alternatives like metformin. Glipizide is another common oral antidiabetic drug but belongs to a different class with different mechanisms of action and side effect profiles.
Educationally, this question helps reinforce the importance of drug classification and understanding the mechanisms of action of commonly prescribed medications for diabetes management. It highlights the need for healthcare providers to be familiar with the different classes of oral hypoglycemic agents to make appropriate treatment choices based on individual patient needs and characteristics. This knowledge is essential for optimizing patient outcomes and minimizing medication-related risks in clinical practice.